US Codex
Bill
Notes

Dangerous Synthetic Drug Control Act of 2016

S. 3224 · 114th Congress · Jul 14, 2016 · Lineage

A BILL

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.

Section 1 Short title

This Act may be cited as the “Dangerous Synthetic Drug Control Act of 2016”.

Sec. 2 Treatment of certain designer drugs as schedule I controlled substances

(a)
Cannabimimetic agents— Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)—
(1)
in clause (xiv) by striking “and” at the end;
(2)
in clause (xv) by striking the period and inserting a semicolon; and
(3)
by adding at the end the following:

“(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251);

“(xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073);

“(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302);

“(xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA);

“(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22);

“(xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA);

“(xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24);

“(xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201);

“(xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA);

“(xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and

“(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MACHMINACA).”

(b)
Synthetic opioids— Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following:

“(43) Butyryl fentanyl.

“(44) beta-Hydroxythiofentanyl.

“(45) Acetyl fentanyl.”

(c)
Other drugs— Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following:

“(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone).

“(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB).

“(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB).

“(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).

“(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI).

“(34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly).

“(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC).

“(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM).”